Infectious disease screening is a cornerstone of global and community health, yet traditional sample collection methods can be logistically complex and hazardous to handle. Dried blood spot (DBS) testing offers an often transformative alternative. With just a few drops of blood collected from a finger prick, DBS enables safe, simple, and scalable diagnostics, especially in resource-limited or remote settings.
A significant yet often overlooked advantage of DBS testing is: once blood samples have dried, the sample is no longer infectious. This dramatically reduces the risk to those handling, storing, or transporting the sample and makes DBS an ideal method for infectious disease surveillance worldwide. Let’s explore how dried blood tests work, why they are often safer than venous draws, and which areas already benefit from DBS testing.
DBS collection is straightforward. A lancet is used to prick the finger, and drops of blood are applied to a specially designed filter paper card. Once the sample has dried thoroughly, it is sealed in protective packaging and sent to a laboratory for analysis and subsequent delivery of testing results. The simplicity of this method eliminates the need for phlebotomists, cold-chain logistics, or fragile glass tubes.
Unlike serologic tests using liquid blood specimens, dried blood poses a negligible risk of pathogen transmission. This is a critical factor in large-scale screening efforts or in regions dealing with infectious outbreaks. Benefits of non-infectious dried samples include:
In outbreak zones or high-prevalence areas, DBS offers a secure way to collect biological data without increasing exposure risks.
Dried blood spot samples can be used to screen for a wide range of infectious diseases, including:
Some programs even perform multiplex testing on a single DBS card, analyzing multiple infections from one small sample.
DBS is uniquely positioned to serve the needs of global health initiatives, public health programs, and decentralized care models. Key advantages include:
From mobile testing units to public health campaigns, DBS helps bring diagnostic capacity closer to where it’s needed most.
Modern laboratories use validated methods like ELISA and PCR adapted specifically for dried matrices. Numerous studies have demonstrated that DBS can offer sensitivity and specificity comparable to venous blood for many infectious disease tests.
Additionally, dried samples are more stable during transit and less prone to logistical errors (e.g., hemolysis, leakage, or sample degradation), reducing rejection rates and improving turnaround times.
DBS is already being used in:
Its adaptability makes it valuable for both acute outbreak management and long-term epidemiological tracking of communicable diseases.
At RDA Spot, we believe that sample quality drives diagnostic confidence. Our DBS kits are engineered to support infectious disease screening from the ground up:
With roots in scientific rigor and a mission to expand access to diagnostic tools, RDA Spot partners with labs, health systems, and public health programs to ensure the success of DBS-based initiatives. We help bridge the gap between innovative microsampling and real-world impact.
Interested in DBS Testing Solutions?
Dried blood spot testing offers a safe, simple, and scalable solution to infectious disease screening. By eliminating the hazards of handling liquid blood and simplifying logistics, DBS empowers healthcare providers and public health workers to expand testing into places and populations that need it most.
As trusted partners in this mission, RDA Spot continues to advance the tools and standards that make high-quality DBS testing possible; helping shape a healthier, more accessible future for all.